Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward Robert Scheffer Cliff

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
The New England Journal of Medicine|June 15, 2026
Immunosuppression-Associated Peripheral T-Cell LymphomaEdward Robert Scheffer Cliff, Melita Kenealy
Blood|January 16, 2026
Global access to commercial CAR T cells: A cross-sectional study of health technology assessment in the G20Alex Y Ge, William B Feldman, Martin F Kaiser, et al.
Blood|February 17, 2026
Time of infusion does not significantly impact outcomes following CAR T-cell therapy in large B-cell lymphomaMark R Dowling, Edward Robert Scheffer Cliff, Anthony Jeffrey, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
The New England Journal of Medicine|June 15, 2026
Immunosuppression-Associated Peripheral T-Cell LymphomaEdward Robert Scheffer Cliff, Melita Kenealy
Blood|January 16, 2026
Global access to commercial CAR T cells: A cross-sectional study of health technology assessment in the G20Alex Y Ge, William B Feldman, Martin F Kaiser, et al.
Blood|February 17, 2026
Time of infusion does not significantly impact outcomes following CAR T-cell therapy in large B-cell lymphomaMark R Dowling, Edward Robert Scheffer Cliff, Anthony Jeffrey, et al.
Pageof 1